COMBINATION TREATMENT EFFECT OF HABBATUSSAUDA (NIGELLA SATIVA) AND ALLOPURINOL FOR HYPERURICEMIA
Keywords:
Allopurinol, Habbatussauda, Hyperuricemia, Nigella SativaAbstract
More than 50% of hyperuricemia patients could not maintain a reduction in serum urate at the most commonly used dose of Allopurinol as initial urate lowering drug. Habbatussauda (Nigella sativa) has been shown to increase excretion of urate in pre clinical studies. This research studied the combination effects of Habbatussauda and Allopurinol to induce the effects and to reduce the required high doses of Allopurinol. The design of this study was experimental using a pretest posttest with control group design. This study used 24 mice (Mus muscullus) which were divided into: the negative control group (aquadest), the positive control group that was given Kalium Oxonat as an induction of hyperuricaemia and Allopurinol, the treatment group 1 (Kalium Oxonat and Habbatussauda), and the treatment group 2 (Kalium Oxonat and combination of Allopurinol and Habbatussauda). Statistical analysis was carried out to test the differences in blood urate level before and after treatment, using One-Way ANOVA and Post Hoc Bonferroni. This study found decrease in urate level in the positive control group and all treatment groups which was significantly different between groups (p < 0,05). Nevertheless, the reduction in urate level in Allopurinol group was greater insignificantly than in Habbatussauda and Allopurinol combination group (p > 0,05). This study concluded that Habbatussauda does not have the potential to increase antihyperuricemia effect of Allopurinol.
References
Dera AA, Rajagopalan P, Alfhili MA, Ahmed I, Chandramoorthy HC. Thymoquinone attenuates oxidative stress of kidney mitochondria and exerts nephroprotective effects in oxonic acid-induced hyperuricemia rats. BioFactors. 2020;46(2):292-300. doi:10.1002/BIOF.1590
Clarson LE, Hider SL, Belcher J, Heneghan C, Roddy E, Mallen CD. Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK Clinical Practice Research Datalink. Ann Rheum Dis. 2015;74(4):642-647. doi:10.1136/ANNRHEUMDIS-2014-205252
Muhtadi, Wahyuningtyas N, Suhendi A, Heryani S. MICROBIOLOGYActivities of The Combined Extracts of Tempuyung (Sonchus arvensis) and Black Cumin (Nigella sativa) Against Xanthine Oxidase Inhibition on Hyperuricemic Mice. Published online October 30, 2015. Accessed February 7, 2023. http://publikasiilmiah.ums.ac.id/handle/11617/6195
Kuo CF, Grainge MJ, Zhang W, Doherty M. Global epidemiology of gout: prevalence, incidence and risk factors. Nat Rev Rheumatol 2015 1111. 2015;11(11):649-662. doi:10.1038/nrrheum.2015.91
Hay CA, Prior JA, Belcher J, Mallen CD, Roddy E. Mortality in Patients With Gout Treated With Allopurinol: A Systematic Review and Meta-Analysis. Arthritis Care Res. 2021;73(7):1049-1054. doi:10.1002/ACR.24205/ABSTRACT
Kuo CF, Luo SF. Risk of premature death in gout unchanged for years. Nat Rev Rheumatol 2017 134. 2017;13(4):200-201. doi:10.1038/nrrheum.2017.27
Alghamdi YS, Soliman MM, Nassan MA. Impact of Lesinurad and allopurinol on experimental Hyperuricemia in mice: biochemical, molecular and Immunohistochemical study. BMC Pharmacol Toxicol. 2020;21(1). doi:10.1186/S40360-020-0386-7
Tse T, Wu B, Vagholkar S, Willcock S. Allopurinol for gout: Consider the case for limited HLA-B*5801 screening. Aust J Gen Pract. 2022;51(10):813-814. doi:10.31128/AJGP-12-21-6264
Yu KH, Yu CY, Fang YF. Diagnostic utility of HLA-B*5801 screening in severe allopurinol hypersensitivity syndrome: an updated systematic review and meta-analysis. Int J Rheum Dis. 2017;20(9):1057-1071. doi:10.1111/1756-185X.13143
Stamp LK, Barclay ML. How to prevent allopurinol hypersensitivity reactions? Rheumatology. 2018;57(suppl_1):i35-i41. doi:10.1093/RHEUMATOLOGY/KEX422
Bardin T, Keenan RT, Khanna PP, et al. Lesinurad in combination with allopurinol: a randomised, double-blind, placebo-controlled study in patients with gout with inadequate response to standard of care (the multinational CLEAR 2 study). doi:10.1136/annrheumdis-2016-209213
Sung YY, Kim DS. Synergistic Impacts of Alpinia oxyphylla Seed Extract and Allopurinol against Experimental Hyperuricemia. Biomed Res Int. 2022;2022. doi:10.1155/2022/2824535
Wu XH, Wang CZ, Wang SQ, et al. Anti-hyperuricemia effects of allopurinol are improved by Smilax riparia, a traditional Chinese herbal medicine. J Ethnopharmacol. 2015;162:362-368. doi:10.1016/J.JEP.2015.01.012
Qaseem A, Harris RP, Forciea MA, et al. Management of acute and recurrent gout: A clinical practice guideline from the American College of Physicians. Ann Intern Med. 2017;166(1):58-68. doi:10.7326/M16-0570/ASSET/IMAGES/LARGE/M160570FF1_FIGURE_SUMMARY_OF_THE_AMERICAN_COLLEGE_OF_PHYSICIANS_GUIDELINE_ON_MANAGEMENT_OF_ACUTE.JPEG
Sutoko B, Hellmi RY, W IV, L SA. Randomized Controlled Trial of Herbal Extracts (Eugenia polyantha, Apium graveolens, Nigella sativa) and Allopurinol Effect on Serum Uric Acid, Urinary Uric Acid and High Sensitivity C-Reactive Protein Levels in Subject with Hyperuricemia. Indones J Rheumatol. 2019;11(2):2019. doi:10.37275/IJR.V11I2.112
Yimer EM, Tuem KB, Karim A, Ur-Rehman N, Anwar F. Nigella sativa L. (Black Cumin): A Promising Natural Remedy for Wide Range of Illnesses. Evid Based Complement Alternat Med. 2019;2019. doi:10.1155/2019/1528635
Nugroho. Mengenal Mencit Sebagai Hewan Laboratorium. Mulawarma Universitas; 2018.
Sugiyanto S, Khalda L, Ndii MZ. Statistical Analysis of Habbatussauda’s Benefits for Health (Blood Pressure, Glucose and Uric Acid). Biol Med Nat Prod Chem. 2019;8(1):7-10. doi:10.14421/BIOMEDICH.2019.81.7-10
Ahmad MF, Ahmad FA, Ashraf SA, et al. An updated knowledge of Black seed (Nigella sativa Linn.): Review of phytochemical constituents and pharmacological properties. J Herb Med. 2021;25:100404. doi:10.1016/J.HERMED.2020.100404
Zhang Y, Liu Y, Qiu H. Association between Dietary Zinc Intake and Hyperuricemia among Adults in the United States. Nutrients. 2018;10(5). doi:10.3390/NU10050568
Wright DFB, Duffull SB, Merriman TR, Dalbeth N, Barclay ML, Stamp LK. Predicting allopurinol response in patients with gout. Br J Clin Pharmacol. 2016;81(2):277. doi:10.1111/BCP.12799
Leung YY, Merriman T, Barcelos A, et al. Physiology of Hyperuricemia and Urate-Lowering Treatments. Front Med | www.frontiersin.org. 2018;1:160. doi:10.3389/fmed.2018.00160
